Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.

Integrin α(V)β(3) plays a critical role in tumor angiogenesis and metastasis. Suitably radiolabeled cyclic RGD peptides can be used for noninvasive imaging of α(V)β(3) expression. The aim of this research was to prepare a multimeric system of technetium-99m-labeled gold nanoparticles conjugated to c[RGDfK(C)] and to evaluate its biological behavior as a potential radiopharmaceutical for molecular imaging of tumor angiogenesis. Hydrazinonicotinamide-GGC (HYNIC-GGC) and c[RGDfK(C)] peptides were synthesized and conjugated to gold nanoparticles (AuNP, 20 nm) by means of spontaneous reaction of the thiol groups of cysteine. The nanoconjugate was characterized by TEM, FT-IR, UV-vis, XPS, and Raman spectroscopy. To obtain (99m)Tc-HYNIC-GGC-AuNP-c[RGDfK(C)] ((99m)Tc-AuNP-RGD), the (99m)Tc-HYNIC-GGC radiopeptide was first prepared and added to 1.5 mL of AuNP solution (1 nM) followed by c[RGDfK(C)] (10 μL, 50 μM) at 18 °C with stirring for 15 min. Radiochemical purity (RP) was determined by size-exclusion HPLC and ITLC-SG analyses. In vitro binding studies were carried out in α(V)β(3) receptor-positive C6 glioma cancer cells. Biodistribution studies were accomplished in athymic mice with C6-induced tumors with blocked and nonblocked receptors, and images were obtained using a micro-SPECT/CT. TEM and spectroscopy techniques demonstrated that AuNPs were functionalized with peptides. RP was 96 ± 2% without postlabeling purification. (99m)Tc-AuNP-RGD showed specific recognition for α(V)β(3) integrins expressed in C6 cells, and 3 h after i.p. administration in mice, the tumor uptake was 8.18 ± 0.57% ID/g. Micro-SPECT/CT images showed evident tumor uptake. (99m)Tc-AuNP-RGD demonstrates properties suitable for use as a target-specific agent for molecular imaging of tumor α(V)β(3) expression.

[1]  Pablo D. Jadzinsky,et al.  Structure of a Thiol Monolayer-Protected Gold Nanoparticle at 1.1 Å Resolution , 2007, Science.

[2]  V. Krishnakumar,et al.  FT Raman and FT-IR spectral studies of 3-mercapto-1,2,4-triazole. , 2004, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[3]  M. Camacho-López,et al.  Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging. , 2010, Journal of biomedical nanotechnology.

[4]  Tobias Vossmeyer,et al.  Self-Assembled Gold Nanoparticle/Alkanedithiol Films: Preparation, Electron Microscopy, XPS-Analysis, Charge Transport and Vapor-Sensing Properties , 2003 .

[5]  Håkan Wallin,et al.  Kupffer cells are central in the removal of nanoparticles from the organism , 2007, Particle and Fibre Toxicology.

[6]  H. Kim,et al.  Spectroscopic identification of S-Au interaction in cysteine capped gold nanoparticles. , 2006, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[7]  D. Astruc,et al.  Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum‐Size‐Related Properties, and Applications Toward Biology, Catalysis, and Nanotechnology. , 2004 .

[8]  Alexandra Schneider,et al.  Ultrafine particles and platelet activation in patients with coronary heart disease – results from a prospective panel study , 2007, Particle and Fibre Toxicology.

[9]  Jesus M de la Fuente,et al.  Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. , 2005, Bioconjugate chemistry.

[10]  C. Decristoforo,et al.  Radiolabelled RGD peptides and peptidomimetics for tumour targeting. , 2009, Frontiers in bioscience.

[11]  Stan W. Casteel,et al.  Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity , 2010, Proceedings of the National Academy of Sciences.

[12]  W. Cai,et al.  (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  Irshad Hussain,et al.  Rational and combinatorial design of peptide capping ligands for gold nanoparticles. , 2004, Journal of the American Chemical Society.

[14]  Giovanna Speranza,et al.  Gold nanoparticles capped by peptides , 2007 .

[15]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[16]  Weibo Cai,et al.  Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging , 2008, Nature Protocols.

[17]  R. Weissleder,et al.  Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.

[18]  W. Cai,et al.  64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor αvβ3 Integrin Expression , 2007, Journal of Nuclear Medicine.

[19]  P. Callis,et al.  Resonance Raman studies of guanidinium and substituted guanidinium ions , 1990 .

[20]  E. Giralt,et al.  How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for beta-amyloid fibrils. , 2008, Bioconjugate chemistry.

[21]  C. Decristoforo,et al.  [99mTc]HYNIC-RGD for imaging integrin αvβ3 expression , 2006 .

[22]  Fernando Albericio,et al.  Peptides and metallic nanoparticles for biomedical applications. , 2007, Nanomedicine.

[23]  U. Haberkorn,et al.  Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding. , 2010, Nuclear medicine and biology.

[24]  Feng Gao,et al.  RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy. , 2010, Molecular pharmaceutics.

[25]  M. Camacho-López,et al.  (99m)Tc-labelled gold nanoparticles capped with HYNIC-peptide/mannose for sentinel lymph node detection. , 2011, Nuclear medicine and biology.

[26]  Shuang Liu.  Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency. , 2009, Bioconjugate chemistry.

[27]  Shuang Liu.  Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3 Targeted Radiotracers for Tumor Imaging , 2006 .

[28]  H. Dai,et al.  In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.

[29]  S. Gambhir,et al.  Quantitative PET Imaging of Tumor Integrin αvβ3 Expression with 18F-FRGD2 , 2006 .

[30]  Priyabrata Mukherjee,et al.  Biological properties of "naked" metal nanoparticles. , 2008, Advanced drug delivery reviews.

[31]  B. Ocampo-García,et al.  Gold nanoparticles conjugated to [Tyr3]octreotide peptide. , 2008, Biophysical chemistry.

[32]  Jeremy J Mao,et al.  Labeling of mesenchymal stem cells by bioconjugated quantum dots. , 2007, Nano letters.

[33]  D. M. Briercheck,et al.  Modeling Vibrational Spectra of Amino Acid Side Chains in Proteins: Effects of Protonation State, Counterion, and Solvent on Arginine C−N Stretch Frequencies† , 1999 .